27 November 2024

Dermatology Pharmaceuticals

New consensus guidelines for oral minoxidil in hair loss

13 November 2024

Melanoma Pharmaceuticals

10 years on, Nivo continues to increase melanoma survival

4 September 2024

Pharmaceuticals

Medications for alcohol use disorder: the time is now

21 August 2024

Allergies Pharmaceuticals TGA

Needle-free adrenaline wins FDA green light

7 August 2024

Pharmaceuticals

NT looks to follow QLD’s lead on pharmacy

24 July 2024

Bullous Pemphigoid Paediatrics Pharmaceuticals

JAK inhibitor helps beat infantile bullous pemphigoid

12 June 2024

Dermatitis/Eczema Pharmaceuticals

Call for calm over topical steroid withdrawal reports

15 May 2024

Media Pain Pharmaceuticals

Opioids on the silver screen

1 May 2024

Pain Pharmaceuticals

Under half of fibromyalgia patients use evidence-based drugs

1 May 2024

Pharmaceuticals Public Health

Fresh call to up-schedule modified-release paracetamol

1 May 2024

Atopic Dermatitis Pharmaceuticals Psoriasis

PBAC tick for new psoriasis, HS and AD options

17 April 2024

Acne Pharmaceuticals

Derms prescribe the most antibiotics: US study

17 April 2024

Allergies Pharmaceuticals

Day-to-day protection against food allergy on the horizon

20 March 2024

Hidradenitis Suppurativa Pharmaceuticals

New BTK inhibitor shows promise in hidradenitis suppurativa

6 March 2024

Pharmaceuticals

Oral morphine substitute approved

6 March 2024

Pharmaceuticals Urticaria

Can a new JAK inhibitor help urticaria?